Clinically, CCR3 expression in tumor specimens shows a positive correlation with advanced histological grades, suggesting that CCL11/CCR3 signaling may drive tumor progression and metastatic potential in CCR3-positive RCC [60]. This evidence concerns the gene CCL11 and neoplasm.